This page uses JavaScript to provide reader feedback and other valuable features. You may want to consider downloading one of the newer browsers in order to take advantage of these features. How to join?
Cancer.gov
 
Cancer.gov The CIRB logo Home How to Join Studies
Participant's Area FAQs Contacts
bar The CIRB Initiative Board Member Roster CIRB Feedback Form
bar bar How it Works Meeting Information Links
bar Activity Updates
  bar bar bar bar
      bar bar
How to join?

In order for your IRB to access CIRB review documents and to utilize the facilitated review mechanism, your institution must formally enroll in the Initiative. To join the Initiative, institutions

  • must have their own functioning IRB;

  • be actively enrolling patients in Cooperative Group adult Phase 3 clinical trials -or- Pilot, Phase 2 or Phase 3 pediatric clinical trials;

  • possess a valid assurance (FWA)

The enrollment materials can be sent electronically or can be downloaded from this webpage. The Request for 30-Day NCI CIRB Website Access Form is available on this webpage for those interested in joining, but would like to review CIRB approved studies prior to joining.

CIRB Operations Office staff are available to assist you with the enrollment process at ncicirbcontact@emmes.com or toll-free at 1-888-657-3711.
     
   
bar   back to top back to top arrow   
About this site Privacy Policy Contact CIRB Webmaster bar bar bar
 
Cancer.gov National Institutes of Health Department of Health and Human Services FirstGov.gov